|
IGENE Biotechnology, Inc. - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for IGENE Biotechnology, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
IGENE Biotechnology, Inc.. The Group's principal activity is to develop, manufacture and market industrial microbiology and related biotechnology products. AstaXin (R) is the registered trademark of the Group. AstaXin is a natural source of astaxanthin, a pigment which imparts the characteristic red color to the flesh of salmon, trout, prawns and certain other kind of fish and shellfish. The Group's products are value added specialty biochemical products derived from abundant, inexpensive and renewable agricultural residues and wastes through fermentation, physical and chemical separation and related chemical and biochemical engineering technologies. The Group mainly operates in the United States.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
